Teaching tolerance: New approaches to enzyme replacement therapy for Pompe disease

Babies born with Pompe disease require life-long treatment with enzyme-replacement therapy (ERT). Despite the human origin of the therapy, recombinant human lysosomal acid α glucosidase (GAA, rhGAA), ERT unfortunately leads to the development of high titers of anti-rhGAA antibody, decreased effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Cousens, Leslie P., Mingozzi, Federico, van der Marel, Sander, Su, Yan, Garman, Richard, Ferreira, Valerie, Martin, William, Scott, David W., De Groot, Anne S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660767/
https://www.ncbi.nlm.nih.gov/pubmed/23095864
http://dx.doi.org/10.4161/hv.21405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660767/
https://www.ncbi.nlm.nih.gov/pubmed/23095864
http://dx.doi.org/10.4161/hv.21405

Ejemplares similares